Lexicon Pharmaceuticals (LXRX) EBT Margin Growth (3y) (2013 - 2025)
Lexicon Pharmaceuticals (LXRX) EBT Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 7.47 Mn |
| Dec 31, 2023 | -404,783.00 |
| Jun 30, 2023 | 26.34 Mn |
| Jun 30, 2022 | -7.20 Mn |
| Dec 31, 2020 | -268,379.00 |
| Jun 30, 2020 | -28.07 Mn |
| Mar 31, 2020 | -59,260.00 |
| Dec 31, 2019 | -48,859.00 |
| Mar 31, 2019 | -64,499.00 |
| Dec 31, 2018 | -16,655.00 |
| Sep 30, 2018 | 586,184.00 |
| Jun 30, 2018 | 726,656.00 |
| Mar 31, 2018 | 140,466.00 |
| Dec 31, 2017 | -5,699.00 |
| Sep 30, 2017 | 962,359.00 |
| Jun 30, 2017 | 364,057.00 |
| Mar 31, 2017 | 1.09 Mn |
| Dec 31, 2016 | 104,346.00 |
| Mar 31, 2016 | 694,525.00 |
| Dec 31, 2015 | 1.16 Mn |